Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Nov;18(5):656–660. doi: 10.1128/aac.18.5.656

Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.

J B Lecaillon, J L Hirtz, J P Schoeller, G Humbert, W Vischer
PMCID: PMC284071  PMID: 7447423

Abstract

The pharmacokinetic parameters of cefroxadin and cephalexin were compared after simultaneous oral administration of the two cephalosporins to 21 subjects. The influence of the dose, the formulation, and food intake on these parameters was investigated. Both drugs were equally well absorbed from all of the tested formulations; identical percentages of the dose were recovered in the urine in all cases. The elimination half-life of cefroxadin and, consequently, the area under the plasma concentration-time curve were about 10% less than those of cephalexin. Plasma concentrations and cumulative excretion curves of the two drugs were almost superimposable. Food intake had the same effect on both drugs; absorption was slowed, but the amounts absorbed were almost the same as those in fasted subjects.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Finkelstein E., Quintiliani R., Lee R., Bracci A., Nightingale C. H. Pharmacokinetics of oral cephalosporins: cephradine cephalexin. J Pharm Sci. 1978 Oct;67(10):1447–1450. doi: 10.1002/jps.2600671033. [DOI] [PubMed] [Google Scholar]
  2. Gillett A. P., Wise Penetration of four cephalosporins into tissue fluid in man. Lancet. 1978 May 6;1(8071):962–964. doi: 10.1016/s0140-6736(78)90250-7. [DOI] [PubMed] [Google Scholar]
  3. Greenwood D. In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin. J Antibiot (Tokyo) 1978 Jul;31(7):697–702. doi: 10.7164/antibiotics.31.697. [DOI] [PubMed] [Google Scholar]
  4. Griffith R. S., Black H. R. Cephalexin. Med Clin North Am. 1970 Sep;54(5):1229–1244. [PubMed] [Google Scholar]
  5. Lode H., Stahlmann R., Dzwillo G., Koeppe P. Pharmakokinetische Vergleichsuntersuchungen zur Resorption von drei neuen Cephalosporinen. Verh Dtsch Ges Inn Med. 1978;(84):964–966. [PubMed] [Google Scholar]
  6. Lode H., Stahlmann R., Koeppe P. Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000. Antimicrob Agents Chemother. 1979 Jul;16(1):1–6. doi: 10.1128/aac.16.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nightingale C. H., Greene D. S., Quintiliani R. Pharmacokinetics and clinical use of cephalosporin antibiotics. J Pharm Sci. 1975 Dec;64(12):1899–1926. doi: 10.1002/jps.2600641202. [DOI] [PubMed] [Google Scholar]
  8. Zak O., Vischer W. A., Schenk C., Tosch W., Zimmermann W., Regös J., Suter E. R., Kradolfer F., Gelzer J. CGP 9000: a new orally active, broad-spectrum cephalosporin. J Antibiot (Tokyo) 1976 Jun;29(6):653–655. doi: 10.7164/antibiotics.29.653. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES